T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund BMY Holdings History
T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund's Bristol-Myers Squibb Co Holding Summary
As of 2025-03-31, T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund held 2,684.00 shares of Bristol-Myers Squibb Co(BMY), totaling $163,700.00. This investment constitutes 0.25% of their stock portfolio, and T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2022Q1. And since then T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund has made 5 purchases of BMY, at an average price of $60.06, for a total of 18,442.00 shares. In addition, there have been 7 sales at an average price of $58.55 for 15,758.00 shares. Based on historical transaction data and BMY's current price of $46.92, T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund's estimated gain on his BMY holdings is $-59,185.94, reflecting a -5.34% gain to date.
T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund BMY ($46.92) Holding Chart
T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund BMY ($46.92) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
